
BioTech Oxular raises £27m to treat diabetic eye disease
An Oxford BioTech has raised £27 million to treat diabetic macular edema. The investment int...
An Oxford BioTech has raised £27 million to treat diabetic macular edema. The investment int...
News distribution and analysis firm Cision has acquired Brighton-based social media listening firm...
A Guildford-based IoT connectivity solutions provider has raised £15 million in a strategic invest...
Listed biotechnology firm e-therapeutics has replaced CEO Ali Mortazavi as chair as it splits ...
The call of the washing basket urging you to put another load on, the knock on the door as you take ...
Axis Spine Technologies has raised £2.2 million in a funding round led by ACF Investors, with f...
Connected car firm Verex has appointed a new CEO. Mark Aryaeenia will oversee the expanding ...
SaaS start-up Customer Thermometer has been acquired by Exclaimer. The Brighton-based custome...
An Oxford start-up has launched ‘sky tractor’ tech to help replant billions of hectares of deg...
Immunocore’s flotation in the US has raised $258 million. The pricing of its initial ...
12 noon-1pm - GoToWebinar event with Biramis 25/03/2021
12 noon-1pm - GoToWebinar event with Biramis 29/04/2021
Demystifying Tech: How does Open Banking work? In this week's show host Alistair Hardaker is join...
Demystifying Tech: Is your sports team in breach of GDPR? Could your local sports team in breach ...
Demystifying Tech: What exactly is a 'smart city? In this week's show we're talking folding phone...
Demystifying Tech: The new tech at Abbey Road Studios In this week's show host Alistair Hardaker ...
On the eve of International Women’s Day, BusinessCloud executive editor Chris Maguire says mo...
By Paige Erickson, MD EMEA, Workfront (an Adobe company) There is no doubt that the way...
By Johan Hajji, co-founder, UpperKey With lockdowns still in place across Europe, rental...
By Richard Hibbert, CEO at SureCloud According to a report released by the UN, phishing ...